Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.

16 Jun 2021

$1 million grant awarded to eliminate the need for drug refrigeration

COVID-19 vaccines have been tested, validated and administered to millions of people around the world. But in some countries, the vaccines have yet to arrive in great enough numbers.

16 Jun 2021

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

A new study, released as a preprint on the bioRxiv* server, describes the late-stage clinical trial efficacy of a new vaccine candidate based on a deoxyribonucleic acid (DNA) plasmid platform expressing the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Among different constructs of the vaccine plasmid, the RBD was found to produce the most potent and broad immune response.

16 Jun 2021

Novavax COVID vaccine co-administered with flu vaccine appears safe and effective

Researchers from the UK recently reported the results of a sub-study that evaluates the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine when co-administered with an approved seasonal influenza vaccine.

16 Jun 2021

Prior vaccination against diphtheria and tetanus associated with less severe COVID-19

The researchers found that individuals with registered diphtheria or tetanus vaccinations were less likely to develop severe COVID-19 than people who had only received other vaccinations. The results of this study are posted to the medRxiv* preprint server.

16 Jun 2021

Rapidly evolving SARS-Cov-2 strains may give rise to escape variants

The number of COVID-19 variants is growing rapidly, so much that the scale and scope of mutation may pose a threat to the continuing successful use of the current vaccines and therapies.

16 Jun 2021

Researchers identify specific cells and proteins that control the sneeze reflex

A tickle in the nose can help trigger a sneeze, expelling irritants and disease-causing pathogens. But the cellular pathways that control the sneeze reflex go far beyond the sinuses and have been poorly understood.

16 Jun 2021

New AI model could help predict which viruses are likely to spread from animals to humans

A new model that applies artificial intelligence to carbohydrates improves the understanding of the infection process and could help predict which viruses are likely to spread from animals to humans.

15 Jun 2021

Global leaders pledge to share COVID-19 vaccine doses internationally at the G7 summit

In a landmark agreement at the G7 summit, held in Cornwall, the United Kingdom of Great Britain and Northern Ireland, global leaders have pledged to share COVID-19 vaccine doses internationally, in support of global equitable access and to help end the acute phase of the pandemic.

15 Jun 2021

Study finds low rate of SARS-CoV-2 reinfection for patients with severe illness

A review of more than 9,000 U.S. patients with severe COVID-19 infection showed less than 1% contracted the illness again, with an average reinfection time of 3.5 months after an initial positive test.

15 Jun 2021

Exposure to common cold virus can protect against COVID-19 infection

Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.

15 Jun 2021

Does SARS-CoV-2 show seasonal variation in transmission in temperate countries?

The need to understand how and why such spread occurs is vital to containing it. A new medRxiv* preprint describes a significant reduction in transmission during the summer (by 42%), which is comparable to the impact of the most effective non-pharmaceutical intervention (NPI).

15 Jun 2021

Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study

It has been uncertain whether antibodies produced via this non-canonical pathway are protective against SARS-CoV-2. In a new study, recently released as a preprint on the bioRxiv*server, the neutralization potency of these antibodies is compared with those traditionally produced in germinal center-based antiviral responses.

15 Jun 2021

Benefits and Challenges for XpressAmp™ Direct Amplification Reagents

News-Medical interviews Curtis Knox, Sr Strategic Portfolio Manager at Promega, about using the XpressAmp™ for the direct amplification of reagents.

From Promega Corporation 15 Jun 2021

Carbon-based antimicrobial nanoweapons to fight COVID-19

In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.

15 Jun 2021

Alkaloids show potential as treatments for COVID-19

To further study these organic compounds, researchers from Kermanshah University of Medical Sciences, Iran, and Universidad de Santiago de Chile, Chile, reviewed the role of alkaloids as a potential antiviral, specifically against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They presented the chemistry, plant sources, and antiviral effects of alkaloids and their anti-SARS-CoV-2 effect.

15 Jun 2021

REGEN-COV antibody cocktail shown to significantly lower SARS-CoV-2 viral load

In human trials, the interim analysis of 275 participants showed REGEN-COV quickly reduced viral loads. Moreover, this reduction was much faster in people who did not have a high viral load when they started treatment.

15 Jun 2021

Immune memory responses differ between SARS-CoV-2 and influenza A

Researchers in Canada have shown that the long-lasting immunity that develops following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by different T cell responses than those observed for influenza A virus-specific immune memory.

14 Jun 2021

COVID-19 PCR tests can withstand freeze-drying process

In fighting the COVID-19 pandemic, it's not just the vaccines that require complicated cold supply chains and refrigerated storage. Polymerase chain reaction (PCR) tests -- often considered the "gold standard" of testing -- also have enzymes and reagents that need to be frozen.

14 Jun 2021

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

Researchers at the University of Maryland School of Medicine analyzed data at the 13-hospital University of Maryland Medical System and found public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: Hospital admissions for chronic obstructive pulmonary disease (COPD) were reduced by 53 percent, according to a new study accepted for publication by a peer-reviewed medical journal and currently available at the online journal medRxiv.

14 Jun 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

$1 million grant awarded to eliminate the need for drug refrigeration

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

Novavax COVID vaccine co-administered with flu vaccine appears safe and effective

Prior vaccination against diphtheria and tetanus associated with less severe COVID-19

Rapidly evolving SARS-Cov-2 strains may give rise to escape variants

Researchers identify specific cells and proteins that control the sneeze reflex

New AI model could help predict which viruses are likely to spread from animals to humans

Global leaders pledge to share COVID-19 vaccine doses internationally at the G7 summit

Study finds low rate of SARS-CoV-2 reinfection for patients with severe illness

Exposure to common cold virus can protect against COVID-19 infection

Does SARS-CoV-2 show seasonal variation in transmission in temperate countries?

Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study

Benefits and Challenges for XpressAmp™ Direct Amplification Reagents

Carbon-based antimicrobial nanoweapons to fight COVID-19

Alkaloids show potential as treatments for COVID-19

REGEN-COV antibody cocktail shown to significantly lower SARS-CoV-2 viral load

Immune memory responses differ between SARS-CoV-2 and influenza A

COVID-19 PCR tests can withstand freeze-drying process

COVID-19 public health efforts linked to dramatic decline in COPD hospitalizations

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in